Archive

Category Archives for "Press Releases"

Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd 

Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager in a $5 million offering of Medigus Ltd. (Nasdaq: MDGS), an Israeli technology company developing minimally-invasive tools and direct visualization technology.  

continue reading >>

Estate Planning During COVID-19

COVID-19 is a harsh reminder that life is fragile and unpredictable. The pandemic has caused many people to acknowledge their mortality and to reevaluate their financial circumstances and life goals.  In these rather difficult and uncertain times, the importance of being prepared for a worst-case scenario and having certain essential estate planning documents in place is, unfortunately, paramount.  At a minimum, every client should establish (or update) the following in order to protect themselves, their loved ones, and their legacy:

  • Financial Power of Attorney:  A financial power of attorney gives another person (an “agent”) the authority to manage your financial affairs on your behalf in the event you are physically or mentally unable to do so.  While you can choose the scope of their power, an agent is generally authorized to pay your bills, write checks, make deposits, sell or purchase assets or sign any tax returns or other official documents as if they were you. Without a properly signed power of attorney, no one can represent you or administer your assets unless a court appoints a conservator or guardian. Such a court proceeding is expensive, timely and does not necessarily result in a person that you know or trust handling your affairs.  A power of attorney, which varies by state, can be amended or revoked for as long you are alive and have the requisite mental capacity to do so.  It is advisable to name in the document a “substitute” or “back up” agent to act in the place of your designated agent.  
  • Health Care Proxy:  Similar to a financial power of attorney, a health care proxy authorizes someone to make health care and medical decisions on your behalf in the event you become incompetent or incapacitated.  Many people assume that a spouse or next of kin is automatically authorized to make such decisions, but this is not the case.  Absent a valid health care proxy, any family member who wishes to act on your behalf initiate a lengthy court proceeding for permission to do so.  In this unprecedented medical environment, it is advisable to have a health care proxy that reflects current and accurate information ready and within reach. 
  • Living Will:   A living will, also known as an “advance health care directive,” allows you to specify what end-of-life measures you wish to have administered if you become terminally ill or permanently unconscious and dependent on life support. Without a living will, the decision to remove life support will be up to your attending physicians or close relatives, none of whom may know your exact wishes in this regard.  
  • Last Will and Testament:   A last will and testament (or “will”) allows you to direct the distribution of your property after your death, appoint an executor to oversee the distribution of your assets, and also appoint a guardian to take care of your minor children.  If you do not have a will in place, your property will be distributed in accordance with the “intestacy” statute applicable to your state of domicile and the court will decide on the appropriate person to oversee the administration.  Additionally, if you do not have a will, your beneficiaries could face significant delay in accessing your financial accounts.  Taking the time to create a clear and thoughtful will that expresses your specific intentions will undoubtedly save your beneficiaries from undue confusion, frustration and delay.  Please note that a will operates only on that property titled in your individual.  It does not operate on property that is jointly owned or is governed by a beneficiary designation, such as retirement accounts or life insurance policies.
  • Beneficiary Designations:  Many people own one or more retirement accounts that make up the majority of their wealth but forget how important it is to have a current and complete beneficiary designation for each.  Having a clear understanding of which of your beneficiaries receive what portion of your retirement assets and confirming that on the retirement plan records can avoid unintended tax consequences.  That is because some laws require that the retirement assets flow to a surviving spouse or children while others direct them to your estate.  Either way, an unplanned transfer of retirement proceeds could result in negative tax consequences and fail to benefit the intended recipients.

The Trust and Estate Private Client Group of Sichenzia Ross Ference, LLP, hopes that you and your loved ones are managing to stay safe and healthy.  

Although we have moved to a remote working environment due to the COVID-19 pandemic, we are still available and able to assist you with all of your trust and estate planning needs.

Please contact Robert Birnbaum, Esq., or Carolyn M. Glynn, Esq. if you are interested in learning more.

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

vuzix view the future logo

Press Release – New York, New York – May 13, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares of its common stock at a price of $2.25 per share for gross proceeds of approximately $11,250,000. 

The Sichenzia Ross Ference LLP team was led by partner Gregory Sichenzia, counsel Jeffrey Cahlon, and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.25 per share, for total gross proceeds of approximately $3.15 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

On June 5, 2019, the United States Securities and Exchange Commission (“Commission”) adopted Rule 15l-1 (“Regulation Best Interest”) under the Securities Exchange Act of 1934 (“Exchange Act”), which has a compliance date of June 30, 2020.[1]  Regulation Best Interest became effective September 10, 2019.  Notwithstanding the host of issues arising from the global pandemic, an economic recession and significant market volatility across essentially every sector, the Commission has made clear that the deadline for compliance with Regulation Best Interest and the related Form CRS requirements will not be delayed or extended.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant.  The offering price was $1.10 per unit and $1.099 per pre-funded unit. 

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

beyond air logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.44 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 722,502 American Depositary Shares (ADSs), each representing 600 of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.8 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 3, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,028,574 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $1.75 per ADS.

continue reading >>

SEC Extends Filing Deadlines for Public Companies and Registered Investment Advisers Affected by COVID-19

On March 25, 2020, the Securities and Exchange Commission (the “SEC”) issued new orders extending the filing periods covered by its previously enacted conditional reporting relief for certain public company filing obligations under the federal securities laws, and also extended regulatory relief previously provided to funds and investment advisers whose operations may be affected by COVID-19.

continue reading >>

Business Interruption Insurance

Dear Clients and Friends,

With widespread government ordered shutdowns resulting from the COVID-19 pandemic, companies are understandably concerned with the interruption to their business operations as well as the financial and economic losses that are beginning to mount. In light of this, it is important that companies take the time to look at their existing insurance policies to examine what options are available to mitigate the impact of the COVID-19 pandemic. The viability of a claim for losses under your existing Property, Event and/or Comprehensive General Liability policies caused by a pandemic or “communicable or infectious diseases” will be largely subject to the specific provisions of your company’s insurance policies.

Sichenzia Ross Ference LLP recommends that all its clients carefully review their insurance policies, including without limitation their Property, Event and Commercial General Liability policies, to determine the scope of coverage for business interruption with particular focus on whether any of those policies include or exclude coverage for losses caused by a communicable or infectious disease such as COVID-19.

We, at Sichenzia Ross Ference LLP, continue to think about our clients and friends during these trying times, and, if there are any ways we might be able to help, ask that you contact us.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.7 Million Overnight Bought Offering of Cel-Sci Common Stock

cel sci

Press Release – New York, NY – March 26, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book-running manager in an offering of 630,500 shares of the common stock of Cel-Sci Corporation (NYSE American: CVM), a biotechnology company. The stock was offered at $12.22 per share for gross proceeds of approximately $7.7 million, less underwriting discounts and other offering expenses.  

continue reading >>

Coronavirus (Covid 19) Update

At Sichenzia Ross Ference LLP, people are our priority. As the world struggles to manage through the impact of the coronavirus (COVID-19), we want to assure you that we are committed to supporting our colleagues, clients, friends and communities as effectively as we have through every other crisis over the decades.

  • Our firm is fully operational: We have adapted and activated our business continuity plans to ensure that our lawyers and team members are able to safely serve our clients’ needs and continue operations on an uninterrupted basis, whether working from our offices or remotely.
  • We encourage you to contact us with any concerns that you may have or topics that you would like to discuss; we are here to support you through these challenging times. Please continue to contact us at the same phone numbers and email addresses that you are accustomed to using.
  • As disruptive as these days are for our clients and colleagues, we know that this virus and efforts to stop its spread will have an even greater impact on the most vulnerable members of our society. Our thoughts go out to all those whose health has been or will be affected by this virus, and our gratitude goes to all the first responders and health care workers courageously working every day to help those who are ill.

We are all in this together, and we will get through it together.

Our thoughts are with you and your loved ones to stay safe and be well.

Founding Partner Gregory Sichenzia Featured in Law360 Article on Coronavirus-fueled Market Volatility

Press Release – New York, NY – March 10, 2020 – Sichenzia Ross Ference LLP today shared that founding name partner Gregory Sichenzia was quoted in Law360 by reporter Tom Zanki in his story, “Market Turbulence Throws IPO Pipeline Into Question.” The story discussed market volatility and IPO plans amid the coronavirus outbreak, including commentary from Sichenzia:

No IPOs are scheduled yet for next week, according to New York Stock Exchange and Nasdaq calendars. Sichenzia Ross Ference LLP partner Greg Sichenzia expects that companies that have not launched roadshows yet will wait for stability before moving forward.

“If you can keep your powder dry, you will,” said Sichenzia, who counsels public and private companies.

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it entered into a subscription agreement with certain investors for shares of the company’s 8% Series C Redeemable Preferred Stock at a purchase price of $100,000 per share for gross proceeds of $3,750,000.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock 

digital ally logo

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.15 per share for gross proceeds of approximately $2.9 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Alliance Global Partners as Placement Agent in $10M Registered Direct Offering of Aptorum Group Limited

Aptorum logo

Press Release – New York, NY – February 28, 2020 – Sichenzia Ross Ference LLP announced today that it represented Alliance Global Partners as lead placement agent in a registered direct offering of 1,351,350 Class A ordinary shares of Aptorum Group Limited (Nasdaq: “APM”), a biopharmaceutical company. The offering price was $7.40 per share for gross proceeds of $10 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $4.6 Million Public Offering of Common Stock 

document security systems logo

Press Release – New York, NY – February 25, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, in the underwritten public offering of 22,222,223 common shares, plus 3,333,333 shares from the exercise of the underwriter’s purchase option to cover overallotments, at a price of $0.18 per share for gross proceeds of $4.6 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

medalist diversified reit logo

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate.  The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

duostech logo

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc.  (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering

co crystal pharma inc

Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc.  (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics.  The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).

continue reading >>

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

activegraf logo

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Successfully Defends Client in Hostile Proxy Contest

Press Release – New York, NY – January 7, 2020 – Sichenzia Ross Ference LLP successfully defended its client, Document Security Systems, Inc., against dissident shareholders.  The shareholders abandoned their efforts after filing an insurgent proxy statement relating to the company’s December 9, 2019 annual meeting. The meeting was held as scheduled and the Board’s recommended slate of candidates was elected.

The SRF team was led by partners Gregory Sichenzia, Darrin Ocasio, Marcelle Balcombe, Barrett DiPaolo, and Jay Yamamoto and associate Matthew Siracusa.

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock

cel sci

Press Release – New York, NY – December 30, 2019 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 606,395 shares of the common stock of CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, at an offering price of $9.07 per share, for gross proceeds of $5.5 million. Pursuant to the terms of the underwriting agreement, Aegis has been granted a 45-day option to purchase up to an additional 90,959 shares of CEL-SCI common stock to cover over-allotments.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman and Marcelle Balcombe and associates Grant Levine and Jacob Tabman.

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP Achieves Voluntary Dismissals in Federal Securities Class Action Lawsuit and Shareholder Derivative Action

Press Release – New York, NY – December 16, 2019 – Sichenzia Ross Ference LLP (SRF) achieved voluntary dismissals in two lawsuits on behalf of its client, Vuzix Corporation (“Vuzix” or “Company”), a leading developer and supplier of Smart Glasses and Augmented Reality Glasses.  SRF represented the Company in consolidated class action lawsuits alleging violations of federal securities laws before the United States District Court for the Southern District of New York (“Class Action”), and in consolidated shareholder derivative actions before the New York State Supreme Court for Monroe County (“Derivative Action”).  The Plaintiffs ultimately dropped both actions.

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

beyond air logo

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission.  The private placement shares will not be registered.

continue reading >>

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

relmada

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article

Press Release – New York, NY – December 6, 2019Sichenzia Ross Ference (SRF) trust and estate attorneys Jodi Zimmerman and Robert Birnbaum were quoted in a LegalZoom article entitled Including Your Stepchildren in Your Estate Plan, written by Sandra Beckwith. Zimmerman and Birnbaum elaborate on tips for preparing wills and trusts to include stepchildren and how to effectively communicate your wishes to loved ones.

You can read the full article here.

Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement

H-Cyte

Press Release – New York, NY – December 2, 2019 –  Sichenzia Ross Ference LLP acted as H-Cyte’s counsel in a $6.0 million private placement with FWHC, LLC at a price in excess of the market price. H-Cyte is the owner and operator of innovative medical technology products and services including LungCYTE and The Lung Health Institute. H-Cyte intends to utilize the funds to advance its development of industry-leading medical treatments for chronic lung diseases such as COPD. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q3

srf square banner

Press Release – New York, NY – October 23, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the third quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities. Read PlacementTracker’s full press release here.

Attorneys Selected for Inclusion on 2019 Super Lawyers Lists

Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP, a leading corporate and securities law firm, announced today that seven of its attorneys were recognized by Super Lawyers Magazine for 2019. Those Sichenzia Ross members include:

  • Partner A.R. John Hitchings, Partner Jay Yamamoto, Associate Owen A. Kloter, and Associate Gary Varnavides were all named New York Metro Rising Stars for 2019
  • Founding Partner Michael Ference and Partner Sameer Rastogi were recognized for their work in the Securities Litigation category
  • Founding Partner Gregory Sichenzia was recognized for his work in the Securities and Corporate Finance category

Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – October 15, 2019Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October 18 opening bell.

Mr. Sichenzia will take the stage along with a group of Relmada Therapeutics leaders, including Chief Executive Officer Sergio Traversa, PharmD, MBA. You can tune in October 18 at 9:30am EST on Facebook Live or via the Nasdaq Webcam. 

Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting

New York, NY – October 10, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia and partner Barrett DiPaolo. The up-listing is effective for trading on October 10, 2019, and RLMD’s common stock will trade under its existing stock symbol, “RLMD.”

continue reading >>

Founding Partner Marc J. Ross, Esq. Speaks at CBD Mountain Exposition in Denver, CO

Press Release – New York, NY – October 9, 2019 – Sichenzia Ross Ference LLP founding partner Marc. J. Ross Esq., will speak at the CBD Mountain Exposition on October 12, 2019 at the Colorado Convention Center in Denver, Colorado. His presentation, titled “It’s Legal, Or Is It? – A Look At The Legalities Of CBD,” will observe and dissect the law encompassing CBD to clarify and explain legal issues surrounding CBD. The presentation is part of a two day symposium from October 11-12, 2019 that brings the cannabis and CBD industry together for learning, sharing, connecting and business building.

Please visit the website here to purchase tickets or learn more.

Sichenzia Ross Ference Represents Innovative Cosmetic Concepts in Joint Venture

Press Release – New York, NY – October 4, 2019 – Sichenzia Ross Ference LLP acted as counsel for Innovative Cosmetic Concepts LLC (“ICC”) in a joint venture with an entity controlled by Rachel Levin. ICC is a global manufacturer and distributor of high quality cosmetic and personal care products. Rachel Levin is a social influencer with the fastest growing YouTube Channel in the world “RCH Beauty101” with over 14 million subscribers. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on New Jersey’s Review of CBD Use in Brownie Ingredients

Press Release — September 30, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. was quoted in an NJ.com story entitled CBD is an ingredient in N.J. brownies, beers and high-end dinners. The FDA says that’s illegal. Marc describes outcomes stemming from FDA review, and is quoted on New Jersey’s ambitions for trying to get ahead of the curve and address what they think is right with its citizens.

Please read the full article here.

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Business and Law of Marijuana

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. presented a webinar course for the Clear Law Institute, titled “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Wednesday, September 18, 2019. The presentation, which is Continuing Legal Education (“CLE”) accredited, discussed the interplay between state and federal laws legalizing recreational and/or medical marijuana uses.

To purchase this webinar, please visit the website here and include speaker code MRoss231979 for a 35% discount.

Founding Partner Marc J. Ross, Esq. Speaks About Cannabis at NECANN New Jersey Cannabis Convention

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. spoke  at the New Jersey Cannabis Convention, presented by NECANN on September 15, 2019 at the A.C. Convention Center in Atlantic City. This presentation addressed the “Budding Business Opportunities” and covered a variety of issues ranging from banking, to taxes, to CBD and ethical issues. The two-day symposium will bring the cannabis industry together for learning, sharing, connecting and business building.

Learn more about the event by visiting the website.

Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Bannerman Resources Limited on OTCQB Listing

Press Release – New York, NY – September 18, 2019 – Sichenzia Ross Ference LLP announced today that it sponsored Bannerman Resources Limited (OTCQB: “BNNLF”), an Australian uranium exploration and development company, for the OTCQB. Sichenzia Ross Ference is a qualified firm responsible for providing guidance on OTCQB requirements and recommending membership. The SRF team was led by partner Darrin Ocasio.

Sichenzia Ross Ference Founding Partner Gregory Sichenzia to Moderate Cannabis Panel at the Investor Summit Microcap Conference

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP announced today that founding partner Gregory Sichenzia will moderate the Cannabis panel discussion at the Investor Summit Microcap Conference at 12pmET on September 16th at the Essex House overlooking Central Park in New York City. To register for the event, please click here.

The panel will consist of industry thought leaders including Medicine Man Technologies, Emerald Bioscience, Hillstreet Beverage, Flowr, and Power REIT. The group will discuss the growth of the cannabis industry, recent M&A trends, U.S. regulations, and medical research.

Sichenzia Ross Ference LLP Announces its Gold-Level Sponsorship of the H.C. Wainwright 21st Annual Global Investment Conference

Press Release — September 6, 2019 — New York, NY —Sichenzia Ross Ference LLP is a proud Gold-Level sponsor of the H.C. Wainwright 21st Annual Global Investment Conference. The conference will be held from September 8 through September 10, 2019 at the Lotte New York Palace Hotel.

Many of our partners and clients will be attending the conference, and members of the firm will be available to meet there.

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $2.0 Million Private Placement

Press Release­­ – New York, NY – August 28, 2019 – Sichenzia Ross Ference LLP announced today that it has represented the placement agent in the initial $2.0 million closing of a private placement of common stock of a development stage artificial intelligence software company.  The issuer may raise up to an additional $3.0 million in subsequent closings.  The Sichenzia Ross Ference LLP team was led by partners Michael Ference and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

sigma labs logo

Press Release – New York, NY – August 2, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million.  Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

continue reading >>

SRF Founding Partner Gregory Sichenzia Featured in Authority Magazine Interview Series on Investing in Cannabis

Press Release — August 1, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Gregory Sichenzia was interviewed by Len Giancola, as part of a series on investing in the cannabis industry for Authority Magazine. Authority Magazine frequently profiles thought-leaders and experts spanning multiple industries including business, film, sports and technology.

In his interview, Mr. Sichenzia shared stories and lessons learned from his career as well as tips and insights on what investors need to understand about the growing cannabis industry.

Please read the full Q&A here.

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q2  

Press Release – New York, NY – July 24, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the second quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

vuzix

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share  for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Founding Partner Marc Ross Interviews with CFN Media on Business and Law of Marijuana

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP founding partner Marc Ross participated in an interview with CFN Media to discuss the ever changing landscape of the Cannabis industry. The interview took place after an informative panel discussion about the Business and Law of Marijuana at the Cannabis World Congress Business Exposition at the Jacobs Javits Convention Center in New York City. Please find the full interview here.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock.  The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

medicine man technologies

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference Litigation Partners Marc Ross and Scott Furst Prevail on Multiple Appeals on Behalf of Client in a Multi-Year Southampton Property Dispute

Press Release – New York, NY – May 30, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partners Marc Ross and Scott Furst, together with appellate counsel, prevailed on multiple appeals taken to the Supreme Court New York, Appellate Division: Second Judicial Department.  The appeals sought to reverse a Suffolk County trial court’s denial of a motion to dismiss a lawsuit commenced in 2015 by adjacent property owners who sought and were awarded by the trial court injunctive relief halting an ongoing, residential construction overlooking Shinnecock Bay, in the Town of Southampton.  An earlier, related litigation concerning the property and its compliance with the local zoning laws relating to height and setback requirements, ultimately failed to resolve the dispute and gave rise to the instant lawsuit at which time SRF was engaged by the Appellant to take over the litigation.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

immuron logo

Press Release – New York, NY – May 29, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, Inc. as sole book runner in a $2.0 million Public Offering of American Depositary Shares (ADSs) of Immuron Limited (ASX: “IMC”; NASDAQ “IMRN”).

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Founding Partner Marc Ross Publishes Op-Ed on Business and Legality of CBD

New York, NY – May 10, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that founding partner Marc Ross published an opinion piece on the business and legality of CBD. The piece, titled “Sorting Out the Confusion Regarding CBD,” was featured on Aeroflow Naturals’ education blog, a resource center for all things CBD.

Aeroflow Naturals is a leading provider of CBD and a subsidiary of Aeroflow Healthcare, a premier provider of durable medical equipment (DME) and services in the Southeastern United States.
You can read the full article here.

Sichenzia Ross Ference LLP Congratulates AIT Therapeutics, Inc. on NASDAQ Uplisting

New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented AIT Therapeutics, Inc. (NASDAQ: AITB), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Avital Perlman. The uplisting is effective for trading on May 7, 2019, and AITB’s common stock will trade under its existing stock symbol, “AITB.”

continue reading >>

Litigation Partner Scott Furst Successfully Defeats Appeal In $10,000,000 Insurance Dispute

Press Release – New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partner Scott Furst successfully defeated an appeal taken to the Supreme Court New York, Appellate Division: Second Judicial Department, which sought to vacate a trial court’s complete dismissal of a multi-party, multi-claim lawsuit for damages and to rescind and restore approximately ten million dollars of insurance coverage ($10,000,000.00).  Plaintiffs brought claims that included fraud, breach of contract and violations of the New York State Insurance Law against an insurance agent, insurance agency and insurer.  Plaintiffs commenced their lawsuit in July 2014 and, during almost five years of litigation, Mr. Furst, on behalf of the agent and agency, successfully moved to dismiss the original complaint, defeated a motion to renew and reargue and moved to dismiss the amended complaint from which the appeal was taken.  The Second Department denied the appeal on multiple grounds giving particular emphasis to the Defendants’ evidence that contradicted the Plaintiffs’ allegations.  The Court also concluded that Plaintiffs could not, as a matter of law, state claims against the agent or agency.  Relying on the facts and law presented by SRF, the Second Department also affirmed the trial court granting summary judgment in favor of the insurer and against the Plaintiffs, which was also appealed.

Odierna v. RSK, LLC, 2019 N.Y. App. Div. LEXIS 2573 (2d Dep’t 2019).

daniel scott furst
Latest posts by daniel scott furst (see all)

    Sichenzia Ross Ference LLP Celebrates its 21st Anniversary

    Press Release – New York, NY – May 7, 2019 –  Originally founded on May 5, 1998, Sichenzia Ross Ference LLP celebrates its 21st year of legal excellence and service for its diverse range of clientele.  From its original three founding attorneys SRF has grown to a family of 65 people who remain dedicated to the highest level of legal counsel spanning a number of industries, including but not limited to securities, corporate, real estate, cannabis, trust & estates, litigation and several others.

    Founding Partner Marc Ross Participates in Panel Discussion on Legal Cannabis

    Press Release – New York, NY – April 25, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that founding partner Marc Ross participated in a panel discussion on the future of the legal cannabis industry. The discussion was featured in a recent episode of “Innovators with Jane King,” an interview series hosted by Nasdaq.

    A video of the full discussion can be found here: https://www.youtube.com/watch?v=OUtVZfF-_b0

    Founding Partner Gregory Sichenzia Quoted in Article on How to Determine if Your Company is IPO Ready

    Press Release – New York, NY – April 24, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was recently featured in an article on YouInc, an online resource for entrepreneurs and business owners.

    Greg spoke with reporter Jordan Rosenfield to share insights on when companies should consider an initial public offering (IPO).

    Sichenzia Ross Ference Closes $180 Million Real Estate Portfolio Acquisition on Behalf of Client

    Press Release – New York, NY – April 22, 2019Sichenzia Ross Ference LLP, a leading corporate securities and full service law firm, today announced that it recently closed on an approximately $180 million multifamily real estate portfolio acquisition for one of its clients, a dynamic and growing real estate investment firm.  This complex transaction involved the acquisition of several REIT entities, negotiation of a preferred equity JV component and a multi-million-dollar debt facility on the portfolio of assets.  The Sichenzia Ross Ference LLP team was led by Real Estate partner Anthony Ficara, partner Mendy Piekarski and counsel Michael Wickersham.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

    quest solution

    Press Release – New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Quest Solution, Inc.  (OTCQB: QUES) in the private placement of 16,666,667 unregistered shares of its common stock, at a purchase price of $.30 per share, for gross proceeds of approximately $5,000,000. Investors also received warrants to purchase 16,666,667 shares of common stock at an exercise price of $.35 per share.

    continue reading >>

    Sichenzia Ross Ference LLP Congratulates INmune Bio Inc., on Initial Public Offering

    New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented INmune Bio Inc. (NASDAQ: INMB), in the Company’s Initial Public Offering and subsequent listing on the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Marc Ross and partners David Manno and Thomas Rose. The stock became effective for trading on February 4, 2019, and its common stock trades under the symbol, “INMB.”

    Follow Sichenzia Ross Ference on Twitter: @SichenziaRoss

     

     

    Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

    new age beverage corp. logo

    Press Release – New York, NY – April 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with East West Bank which provides for up to $25 million aggregate principal amount revolving credit facility, which includes a $15 million term loan and a feature to provide an additional $10 million should the company choose to utilize it and a $10 million revolving line of credit.

    continue reading >>

    Sichenzia Ross Ference LLP Announces its Platinum-Level Sponsorship of the 2019 ThinkEquity Conference

    Press Release – New York, NY – March 29, 2019 – Sichenzia Ross Ference LLP is happy to announce its Platinum-Level sponsorship for the 2019 ThinkEquity Conference. The conference will be held on May 2, 2019 at The Mandarin Oriental Hotel in New York, NY.

    Gregory Sichenzia, one of SRF’s founding partners, commented, “We have long been friends of ThinkEquity and are excited to support its growing conference series.”

    Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

    live well

    Press Release – New York, NY – March 28, 2019 – Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that it represented LiveWell Canada Inc. (“LiveWell”), a Canadian CBD company listed on the Canadian Stock Exchange entering the U.S. markets, in a private placement offering of senior secured convertible notes with institutional investors for total aggregate gross proceeds of $15 million, which includes LiveWell’s previously closed $3 million bridge financing.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

    opgen logo

    Press Release – New York, NY – March 28, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.  Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease. The Sichenzia Ross Ference LLP team was led by partners Tom Rose, Gregory Sichenzia and Jay Yamamoto.

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – March 20, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a global cloud software communications platform company, as it closed a $50,000,000 committed senior secured credit facility with Post Road Group. Under the terms of the credit facility, Post Road provided Pareteum an initial loan of $25,000,000 on February 26, 2019, with additional loans in increments of $5,000,000 to be made as requested by Pareteum before the 18-month anniversary of the initial funding date.

    The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associates Grant Levine and Huan Lou.

    Sichenzia Ross Ference LLP

    Founding Partner Marc Ross to Present Legal Webinar on The Conflicting State and Federal Laws Concerning Marijuana, Hemp and CBD

    Press Release – New York, NY – March 11, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that its founding partner Marc J. Ross will present a webinar course at the Clear Law Institute, “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Monday, March 11, 2019 at 3:00 pm.

    continue reading >>

    Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – February 14, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it accepted for exchange shares  of iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity.

    continue reading >>

    Sichenzia Ross Ference Partner Ralph Preite Participates on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” Webinar

    Press Release – New York, NY – February 14, 2019 –  Sichenzia Ross Ference LLP Partner Ralph Preite participated on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” webinar, hosted on February 13th.

    This webinar series examines ethical issues confronted by businesses in a variety of contexts, from so called “grey areas” to those involving outright corruption. The panelists consider and recommend different approaches to ethical decision-making and the lawyer’s role in advising business clients.

    To learn more, please click here.

    Sichenzia Ross Ference LLP Adds Jeff D’Angelo as Corporate & Securities Partner

    NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Sichenzia Ross Ference, a leading securities and corporate law firm, announced today that Jeff D’Angelo will join the firm as a Partner in the firm’s Corporate and Securities practice, effective on February 19, 2019.

    Prior to joining SRF, Mr. D’Angelo worked with publicly-traded company Document Security Systems, Inc. in a variety of roles, including Vice-President and General Counsel. Prior to joining DSS, Mr. D’Angelo practiced corporate law for several years, and also served as Managing Director at Prudential Financial, heading its Western New York financial operation and overseeing more than 60 sales associates and managers.

    Mr. D’Angelo will represent SRF’s clients in securities law, corporate governance, commercial contracts, general corporate law, mergers & acquisitions, IPOs, technology licensing and corporate finance matters. In 2018, during his tenure as in-house general counsel for DSS, Mr. D’Angelo was nominated for the Western New York Daily Record and Rochester Business Journal’s Corporate Counsel of the Year Award.

    “Sichenzia Ross offers me the perfect transition from my role as in-house general counsel while providing an ideal platform for me to continue representing DSS as outside counsel under the SRF umbrella. I have known Greg Sichenzia for years, as we attended law school together and have collaborated professionally in the past, and I am excited to join a nationally-recognized corporate and securities law firm with such a diverse roster of innovative public company clients,” said Mr. D’Angelo. “I am confident that my experience coupled with Sichenzia Ross’ reputation for excellence will help me to continue to grow the firm’s national corporate practice.”

    Founding partner Gregory Sichenzia welcomed the addition, saying, “We are very glad to have Jeff on board. We worked with him when he was DSS’ general counsel and know that he has the professionalism and character that we seek to attract.”

    Mr. D’Angelo holds a B.S. in General Management from Purdue University, and a law degree from the Benjamin N. Cardozo School of Law.

    About Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

    cellect logo

    Press Release – New York, NY – February 12, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.

    continue reading >>

    Sichenzia Ross Ference LLP Congratulates Zynex, Inc., on NASDAQ Uplisting

    New York, NY – February 8, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Zynex, Inc. (NASDAQ: ZYXI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Tara Guarneri-Ferrara. The up-listing is effective for trading on February 12, 2019, and ZYXI’s common stock will trade under its existing stock symbol, “ZYXI.”

    “We applaud ZYXI on the achievement of this important milestone, one that positions the Company’s to capitalize on its market objectives while it continues to develop its pain management and rehab electrotherapy devices,” said Gregory Sichenzia,  partner of Sichenzia Ross Ference LLP.

    Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

    inmune logo

    Press Release – New York, NY – February 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented INmune Bio Inc. (INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, in an initial public offering at a price of $8.00 per share resulting in gross proceeds of approximately $8,000,000 and listing on the Nasdaq Capital Market under the ticker symbol INMB.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Cannabis Law Group

    Press Release – New York, NY – January 24, 2019 – Sichenzia Ross Ference LLP (“SRF”), a leading corporate securities and full service law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of cannabis related businesses. SRF’s Cannabis Law Group is led by founding partner Marc J. Ross. The full release can also be found here.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Merchant Cash Advance Practice Group

    NEW YORK, Jan. 15, 2019 — Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of alternative commercial financing and merchant cash advance (MCA) companies.

    Led by Sichenzia Ross Ference partner Mendy Piekarski, this multi-discipline group has established expertise in all aspects of the MCA business cycle, including capital formation, asset deployment, brokering arraignments, syndication and participation agreements, regulatory compliance, and litigation. continue reading >>

    Founding Partner Gregory Sichenzia Quoted in Leading Law Trade Publications

    Press Release – New York, NY – January 14, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was featured in two leading law publications, Law.com and Law.360.

    In the Law.com article, Greg spoke with reporter Christine Simmons to share his insight on how the government shutdown may impact public companies and their legal counsel.

    In the Law360 article (subscription required), Greg spoke with Tom Zanki to discuss takeaways from the JP Morgan Healthcare conference in San Francisco.

    Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

    boulder botanicals

    Press Release – New York, NY – January 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented Boulder Botanicals & Biosciences Laboratories, Inc.  (BBBL), a holding company which owns and operates several companies operating within the CBD production, extraction and distribution industries in a private placement of shares of common stock at a price of $1.00 per share resulting in gross proceeds of approximately $5,000,000.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

    china sxt pharmaceuticals

    Press Release – New York, NY – January 4, 2019 – Sichenzia Ross Ference LLP congratulates China SXT Pharmaceuticals, Inc. (the “Company”) (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), on the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. The shares are scheduled to commence trading on the NASDAQ Capital Market today at around 2:05 p.m. ET under the ticker symbol “SXTC.”

    continue reading >>

    Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.

    new age beverage corp. logo

    NEW YORK, Jan. 03, 2019 — Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that its mergers and acquisitions team represented New Age Beverages Corporation (NASDAQ:NBEV) in its acquisition of Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyle company with operations in more than 60 countries worldwide.

    The consideration for the merger was $85 million, comprised of $75 million in cash and $10 million paid in 2,016,480 shares of New Age common stock based on the 40-day volume-weighted average price calculated through December 20, 2018. The transaction was subject to the pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and closed on December 21, 2018.

    The full Sichenzia Ross release can be found here.

    continue reading >>

    1 2 3 5